Pelengaris et al. [24] used a switchable form of the c-Myc protein to make a reversible transgenic model of pancreatic β cell oncogenesis, and found that loss of c-Myc protein up-regulated Bcl-xL expression and suppressed apoptosis, finally resulted in a full spectrum of tumor development, even distant metastasis. Here, MYC is linked to neoplasm.